Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03525808 · ClinicalTrials.gov registry record · NA
AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03525808 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 40 participants.
The verdict
NCT03525808, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
To demonstrate safety and effectiveness of lumen-apposing metal stents for resolution of walled off pancreatic necrosis (WONs) in patients with WONs with solid component \>30%.
Interventions
- DEVICE AXIOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2020-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03525808
The ClinicalTrials.gov registry entry for NCT03525808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AXIOS is the first listed.
NCT03525808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03525808 about?
NCT03525808 is a clinical study titled "AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study". To demonstrate safety and effectiveness of lumen-apposing metal stents for resolution of walled off pancreatic necrosis (WONs) in patients with WONs with solid component \>30%.
What is the current status of trial NCT03525808?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-09-05. Estimated completion is 2020-10-02.
What interventions are being tested in trial NCT03525808?
The interventions under investigation include: AXIOS (DEVICE).
Who is sponsoring clinical trial NCT03525808?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.